Market News & Trends
CordenPharma Enters Oligonucleotide API Manufacturing Market to Further Strengthen CDMO Offering
CordenPharma recently announced its expansion into the oligonucleotide Active Pharmaceutical Ingredient (API) development and manufacturing market. Dr. Christian Ewers, Vice President Operations, CordenPharma, indicated the…
LEO Pharma Enters Biologics Through Strategic Partnership With AstraZeneca
LEO Pharma recently announced it is a significant step closer to realizing its vision of becoming the preferred dermatology care partner following a strategic partnership…
Tesaro Raises $377 Million
TESARO, Inc. recently announced it has commenced an underwritten public offering of $300 million of its common stock. In connection with this offering, TESARO plans…
Merck Provides Results of Pivotal Study That Confirms Addition of Erbitux to FOLFOX Significantly Improves Outcomes
Merck presented data at the ESMO 18th World Congress on Gastrointestinal Cancer (WCGC) from the pivotal Phase III TAILOR study in patients from China, the…
Aeterna Zentaris & Orient Europharma Sign License Agreement
Aeterna Zentaris Inc. and Orient EuroPharma Co., Ltd. recently announced the signing of an exclusive license agreement between the company and Cyntec Co., Ltd., an…
RiboMed Biotechnologies & Tocagen Collaborate to Analyze Epigenetic Prognostic Markers, Including MGMT, in Recurrent Brain Tumors
RiboMed Biotechnologies, Inc. and Tocagen Inc. recently announced a collaboration to analyze potential epigenetic prognostic and predictive markers, including the gene for the DNA repair…
Relmada Therapeutics Secures First European Patent Covering LevoCap ER
Relmada Therapeutics, Inc. recently announced it has been granted a patent from the European Patent Office (EPO) for compositions and methods of use for its…
West’s SmartDose(®) Drug Delivery Technology Platform Selected by Amgen for Pushtronex™ System
On-body Infusor with Prefilled Cartridge to Deliver Monthly Single Dose of Repatha® (evolocumab) West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in…
Global Urological Cancers Market Will Double to $35.9 billion by 2022
The urological cancers market, including bladder, kidney, prostate, and testicular cancer, will increase from $17.9 billion in 2015 to $35.9 billion by 2022, at a…
Catalent to Commercially Supply Palatin Technologies’ New Bremelanotide FSD Product in Pen Injectors
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it…
Major Players in Type 2 Diabetes Shifting Focus to Pricing to Maintain Market Share
The highly mature type 2 diabetes (T2D) market, which is forecast to be valued at $58.7 billion by 2025, will see pharmaceutical companies prioritizing competitive…
Catalent to Commercially Supply Palatin Technologies’ New Bremelanotide FSD Product in Pen Injectors
Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that it…
Major Players in Type 2 Diabetes Shifting Focus to Pricing to Maintain Market Share
The highly mature type 2 diabetes (T2D) market, which is forecast to be valued at $58.7 billion by 2025, will see pharmaceutical companies prioritizing competitive…
XBiotech Signs Exclusive Licensing Agreement With Megapharm
XBiotech Inc., developer of next-generation True Human antibody therapies, recently announced that it has entered into an exclusive licensing agreement with Megapharm Ltd., to commercialize…
MilliporeSigma to Develop Next-Generation Purification Processes
MilliporeSigma has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.…
Kitov's Lead Drug Achieves Manufacturing Milestone Ahead of Planned NDA Filing With US FDA
Kitov Pharmaceuticals, an innovative biopharmaceutical company focused on late-stage drug development, recently announced that Dexcel Pharma, Kitov's manufacturing partner, has successfully completed an initial stability…
Evonik Acquires Transferra Nanosciences Inc.
Evonik and Transferra Nanosciences, Inc., formerly known as Northern Lipids Inc., recently announced they have signed an asset purchase agreement on June 21, 2016, to…
CordenPharma Caponago Announces Successful Approval of New Sterile Injectable Facility
CordenPharma recently announced the completion and approval of its aseptic filling line in CordenPharma Caponago (IT) by the Italian AIFA for clinical and commercial supply.…
Bio-Path Holdings Announces Collaboration With Thomas Jefferson University
Bio-Path Holdings, Inc. recently announced it has entered into a sponsored research agreement with Thomas Jefferson University to investigate DNAbilize antisense DNA technology for the…
ERT Develops Industry’s First Integration of Continuous Glucose Monitoring Data & eCOA
ERT, a leading provider of high-quality patient data collection solutions for use in clinical drug development, recently announced a data license agreement with Dexcom to…
